<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01155310</url>
  </required_header>
  <id_info>
    <org_study_id>ALMED-07-C3-009</org_study_id>
    <nct_id>NCT01155310</nct_id>
  </id_info>
  <brief_title>Efficacy of Helium/Oxygen Compared to Air/Oxygen in Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)</brief_title>
  <acronym>ECHO/ICU</acronym>
  <official_title>An International Phase III Randomised Trial Comparing in Severe Exacerbations of Chronic Obstructive Pulmonary Disease the Efficacy of Helium/Oxygen Versus Air/Oxygen Administered During Spontaneous Breathing and Intermittent Non-Invasive Ventilation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Air Liquide Santé International</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Air Liquide Santé International</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the study is to evaluate the efficacy of Helium/Oxygen (He/O2)
      78%/22% compared to a conventional Air/O2 mixture in reducing endotracheal intubation rate
      and mortality in patients with severe hypercapnic exacerbations of Chronic Obstructive
      Pulmonary Disease (COPD) during their index Intensive/Intermediate Care Unit (ICU) stay.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients eligible for this study are critically ill patients with COPD admitted in Intensive
      Care Unit for an exacerbation of their chronic disease with hypercapnic acute respiratory
      failure. The patients will receive an Helium/Oxygen mixture or an Air/Oxygen mixture for a
      maximum of 72 hours during Non-Invasive Ventilation (NIV) and NIV-free sessions.

      During NIV sessions, gas mixtures will be administered using a ventilator suitable for NIV
      with either He/O2 or Air/O2 and a NIV facemask.

      Patients will be followed until hospital discharge and then contacted by phone up to the 6th
      month after randomization.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    the observed event rate is lower than expected by the protocol hypothesis.
  </why_stopped>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of NIV failure</measure>
    <time_frame>10 days (average)</time_frame>
    <description>Endotracheal intubation and/or death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of ICU stay and duration of index hospitalisation</measure>
    <time_frame>10 days (average)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of invasive ventilation</measure>
    <time_frame>10 days (average)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>6 months (post-randomization)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medico-economic parameters</measure>
    <time_frame>6 months</time_frame>
    <description>Overall costs and cost-effectiveness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physiological and laboratory parameters</measure>
    <time_frame>10 days (average)</time_frame>
    <description>Systolic and diastolic blood pressures, heart rate, central body temperature, arterial oxygen saturation, haematology and serum biochemistry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of NIV sessions</measure>
    <time_frame>10 days (average)</time_frame>
    <description>Cumulative daily duration of NIV sessions and their number during each of the 3-day treatment period and globally</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time interval between the discharge of the index ICU stay and the first re-admission in ICU for severe exacerbation of COPD</measure>
    <time_frame>6 months (post-randomization)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">446</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Helium/Oxygen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Helium/Oxygen 78%/22% will be administered for a maximum of 72 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Air/Oxygen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Air/Oxygen will be administered for a maximum of 72 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Helium/Oxygen 78%/22%</intervention_name>
    <description>The Helium/Oxygen mixture will be administered during NIV and NIV-free sessions for a maximum of 72 hours using study dedicated devices.
Patients will then receive the Air/Oxygen mixture with usual devices.</description>
    <arm_group_label>Helium/Oxygen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Air/Oxygen</intervention_name>
    <description>The Helium/Oxygen mixture will be administered during NIV and NIV-free sessions for a maximum of 72 hours using study dedicated devices.
Patients will then receive the Air/Oxygen mixture with usual devices.</description>
    <arm_group_label>Air/Oxygen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with known or suspected COPD

          -  Patient presenting current exacerbation of COPD with hypercapnic acute respiratory
             failure

          -  Patient eligible for Non-Invasive Ventilation (NIV)

          -  Patient admitted in an ICU

        Exclusion Criteria:

          -  Patient who had lung transplant

          -  Patient having a contraindication to NIV

          -  Patient with tracheostomy

          -  Patient requiring Oxygen flow rate &gt; 6 L/min or Inspired Oxygen Fraction (FIO2) &gt; 0.50

          -  Patient admitted in the ICU for more than 24 hours and/or having received NIV in ICU
             for more than 6 hours (in total) for the current exacerbation of COPD
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe JOLLIET, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Centre Hospitalier Universitaire Vaudois</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cliniques Universitaires Saint Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Les Cliniques Universitaires UCL Mont Godinne</name>
      <address>
        <city>Yvoir</city>
        <zip>5530</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Angers</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Pellegrin-Tripode</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpitaux de Chartes</name>
      <address>
        <city>Chartres</city>
        <zip>28018</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand - Hôpital ESTAING</name>
      <address>
        <city>Clermont-ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Henri Mondor</name>
      <address>
        <city>Creteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU NICE - Hopital Pasteur</name>
      <address>
        <city>Nice</city>
        <zip>06002</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Européen Georges Pompidou</name>
      <address>
        <city>Paris</city>
        <zip>75908</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer - Hopital Sainte Musse</name>
      <address>
        <city>Toulon</city>
        <zip>83056</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Univeritaria Careggi</name>
      <address>
        <city>Firenze</city>
        <zip>50134</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Universitaires de Genève</name>
      <address>
        <city>Genève</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Abderrahmen Mami</name>
      <address>
        <city>Ariana</city>
        <zip>2080</zip>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Fattouma Bourguiba</name>
      <address>
        <city>Monastir</city>
        <zip>5000</zip>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of North Tees</name>
      <address>
        <city>Stockton on Tees</city>
        <zip>TS19 8 PE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Italy</country>
    <country>Switzerland</country>
    <country>Tunisia</country>
    <country>United Kingdom</country>
  </location_countries>
  <removed_countries>
    <country>Germany</country>
  </removed_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2010</study_first_submitted>
  <study_first_submitted_qc>June 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2010</study_first_posted>
  <last_update_submitted>October 6, 2014</last_update_submitted>
  <last_update_submitted_qc>October 6, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 7, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Exacerbation of COPD</keyword>
  <keyword>Helium/Oxygen</keyword>
  <keyword>ICU</keyword>
  <keyword>Non-Invasive Ventilation</keyword>
  <keyword>Patient with known or suspected COPD</keyword>
  <keyword>patient Admitted in an ICU</keyword>
  <keyword>Patient presenting current exacerbation of COPD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

